<DOC>
	<DOC>NCT00161668</DOC>
	<brief_summary>This study is designed to assess the safety of Mylotarg therapy in routine practice.</brief_summary>
	<brief_title>Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care</brief_title>
	<detailed_description />
	<mesh_term>Leukemia, Myeloid, Acute</mesh_term>
	<mesh_term>Gemtuzumab</mesh_term>
	<criteria>Treated by Mylotarg Provide ICF</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>Leukemia</keyword>
</DOC>